Aug. 3 at 8:53 PM
$CRDF This could be related to speculation about
$AZN and
$BMY talking about mega-merger to create a
$100B oncology powerhouse which could force
$PFE into biotech M&A activity. Anyone that
$PFE had previously had under IGNITE (Cardiff) could in theory be a takeout target. Any concerns around NMS legal issues become a moot point since
$PFE in house counsel would bury and bankrupt NMS.